Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

685
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
685
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

2.1K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

726
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
726
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

4.2K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
4.2K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

71.2K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
71.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

820
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
820

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The anti-inflammatory efficacy of melanocortin drugs is influenced by genetic variation at MC1R.

Scientific reports·2026
Same author

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same author

Resolution Pharmacology: State-of-the-art and therapeutic landscape.

Pharmacological reviews·2025
Same author

The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis.

Arthritis research & therapy·2025
Same author

Molecular Determinants of Neutrophil Extracellular Vesicles That Drive Cartilage Regeneration in Inflammatory Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2024
Same author

An optimised protocol for the detection of lipofuscin, a versatile and quantifiable marker of cellular senescence.

PloS one·2024

Related Experiment Video

Updated: Apr 16, 2026

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.7K

ACTH: The forgotten therapy.

Trinidad Montero-Melendez1

  • 1The William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, Charterhouse Square, EC1M 6BQ, London, United Kingdom.

Seminars in Immunology
|March 2, 2015
PubMed
Summary

Adrenocorticotropic hormone (ACTH) offers anti-inflammatory benefits beyond cortisol production by targeting melanocortin receptors on immune cells. This highlights potential for new, safer ACTH-like drugs for chronic inflammatory diseases.

Keywords:
ACTHDrug discoveryGPCRInflammationMelanocortinPro-resolving mediator

More Related Videos

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K
A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.6K

Related Experiment Videos

Last Updated: Apr 16, 2026

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.7K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K
A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.6K

Area of Science:

  • Immunology
  • Pharmacology
  • Endocrinology

Background:

  • Chronic inflammatory diseases like rheumatoid arthritis present unmet therapeutic needs.
  • Existing anti-inflammatory drugs have limitations, driving interest in repurposing older medications.
  • Adrenocorticotropic hormone (ACTH) has been used clinically since 1952, often as a last resort.

Purpose of the Study:

  • To review the anti-inflammatory actions of ACTH and melanocortin drugs.
  • To explore the role of the melanocortin system in endogenous anti-inflammatory processes.
  • To discuss the potential for developing novel melanocortin-based therapeutics.

Main Methods:

  • Review of existing literature on ACTH, melanocortin receptors, and their biological functions.
  • Analysis of physiological and pharmacological mechanisms of action.
  • Examination of recent advances in G protein-coupled receptor (GPCR) research.

Main Results:

  • ACTH exerts anti-inflammatory effects by interacting with melanocortin receptors on immune cells, independent of cortisol production.
  • Immune cells produce endogenous melanocortin agonists, suggesting an intrinsic anti-inflammatory pathway.
  • The melanocortin system represents a promising target for novel anti-inflammatory drug development.

Conclusions:

  • ACTH possesses significant anti-inflammatory properties mediated through melanocortin receptors.
  • Understanding the melanocortin system reveals potential for developing new drugs with reduced side effects.
  • Targeting melanocortin receptors offers a promising strategy for managing chronic inflammatory conditions.